Background Health state utility values (HSUVs) are required to calculate quality-adjusted life-years (QALYs). They are frequently derived from generic preference-based measures of health. However, such generic measures may not capture health attributes of relevance to specific conditions. In such cases, a condition-specific preferencebased measure (CSPBM) may be more appropriate. Objective This systematic review aimed to identify all published accounts of developing CSPBMs to describe and appraise the methods used. Method We undertook a systematic search (of Embase, MEDLINE, PsycINFO, Web of Science, the Cochrane Library, CINAHL, EconLit, ASSIA and the Health Management Information Consortium database) to identify published accounts of CSPBM development up to July 2015. Studies were reviewed to investigate the methods used to design classification systems, estimate HSUVs, and validate the measures. Results A total of 86 publications were identified, describing 51 CSPBMs. Around two-thirds of these were QALY measures; the remainder were designed for clinical decision making only. Classification systems for 33
Introduction
The quality-adjusted life-year (QALY) is a measure of health-related quality of life (HRQoL) that is frequently used for evaluating the cost effectiveness of healthcare interventions. QALYs are calculated by weighting each year of life according to its quality, on a numerical scale anchored at one (equivalent to full health) and zero (equivalent to being dead), thereby combining length and quality of life into a single measure. These standard 'scaling anchors' enable comparisons to be drawn between different health conditions [1] . QALY weights are frequently sourced from preference-based measures (PBMs) of HRQoL. PBMs provide a standardised health state classification system and a tariff of quality weights for all health states described by the classification system. Generic PBMs, such as the EuroQol EQ-5D [2] , Short-Form 6D [3] or Health Utilities Index [4] , are commonly used. In addition to enabling the cost effectiveness of interventions to be compared across a wide range of conditions, using the common metric of the QALY, PBMs can also be used to inform decision making at an individual patient level or between alternative treatments for the same condition. In the latter case, the PBM need not generate QALY weights on the scale from dead (zero) to full health (1.00). Generic PBMs are designed to be applicable for all health conditions; however, their broad focus has led to some debate around the extent to which they capture aspects of HRQoL of particular relevance to specific conditions. An alternative approach is to use a PBM with a health state classification system that is specific to a particular condition. By focusing on the aspects of health that are most relevant to the condition of interest, these condition-specific PBMs (CSPBMs) potentially offer greater sensitivity and responsiveness [1] .
Here we present a systematic review of the literature describing the development of CSPBMs. The review is structured around the three stages involved in developing a PBM [1] .
The first stage is to construct a classification system consisting of a set of dimensions, each of which represents a health attribute. Each dimension has a number of ordinal levels. Health states are constructed by selecting one level from each dimension [5] . The classification system must be sufficiently concise to be amenable to valuation, typically containing no more than nine dimensions [6] . There are two approaches to developing a classification system: constructing a new instrument (de novo) or deriving one from an existing HRQoL measure [1] . These existing measures often have large numbers of items with several response levels. To produce a classification system that is suitable for valuation, the most appropriate single item is selected to represent each dimension, using statistical analysis of a dataset that contains the original measure [5] .
Second, to use the PBM for the calculation of QALYs, a quality weight, or health state utility value (HSUV), must be assigned to all the health states described by the classification system. Typically, values are obtained directly for a sample of the health states via a valuation survey, in which preferences between different health states are elicited either from a sample of people with the condition or from a sample of the general population. Preference-elicitation techniques include the standard gamble (SG), time trade-off (TTO), visual analogue scales (VAS) and discrete-choice experiments (DCEs). One of two modelling methods is then used to estimate HSUVs for all health states described by the classification system [6] . The first of these is described as the 'composite' approach because valuations are obtained simultaneously for dimensions and dimension levels. Regression models are estimated, in which the dependent variable is the observed HSUV and the independent variables are binary dummy variables representing each level of each dimension. Various criteria can be used to compare the performance of alternative models, enabling a preferred model to be selected. The second method is described as 'decomposed' because dimensions and dimension levels are valued separately, and the results are combined in the modelling phase [5] . In the valuation survey, respondents consider each dimension in isolation and scale the levels of the dimension relative to one another and, in a separate exercise, consider the relative importance, or weighting, of each dimension. HSUVs are estimated by solving a series of equations based on multi-attribute utility theory, using the results of the valuation survey.
Finally, the new PBM should be validated. Brazier et al. [1] recommend assessing the convergent validity between the CSPBM and generic PBMs and comparing them in terms of their discriminative validity and responsiveness. This enables an estimation of the impact on the results of cost-effectiveness analyses of using the CSPBM rather than a generic alternative and indicates whether the CSPBM is better able to capture differences and changes in HRQoL and condition severity. Where the descriptive system has been derived from an existing measure, they suggest that the magnitude of the information lost in the process of reducing the number of items should be estimated by assessing the convergent validity between the CSPBM and its parent measure and by comparing them in terms of their discriminative validity, responsiveness and convergent validity with other relevant measures.
Four previous systematic literature reviews have been undertaken to address research questions that relate to or include the development of CSPBMs. Mortimer and Segal [7] aimed to compare four methods for estimating QALY weights from non-PBMs, including derivation of a PBM from an existing measure, and to determine what effect the choice of method may have on the values generated. Their review included generic and condition-specific measures. Petrillo and Cairns [8] aimed to identify best practice in mapping from condition-specific non-PBMs to generic PBMs and in developing CSPBMs from existing measures. Lin et al. [9] compared the content of CSPBMs and mapping studies with the EQ-5D in order to identify health attributes for which additional, 'bolt-on' dimensions to the EQ-5D may be appropriate. These three reviews did not focus solely on the development of CSPBMs, therefore their search terms were not specifically designed for this purpose, and discussion of the CSPBMs and the methods employed in their development were necessarily brief or absent. None of these reviews included studies in which the classification system was developed de novo. Another systematic review, undertaken by Brazier et al. [1] , focused solely on the methods for the development of CSPBMs, both de novo and from existing instruments. Their literature search identified 26 papers describing the development of 22 instruments up to December 2010. A number of other CSPBMs have been developed since this review. An informal review of the titles, abstracts and keywords of several papers describing the development of CSPBMs suggested that a search strategy incorporating a wider range of search terms could potentially identify additional papers.
Here we present a systematic review based on a more recent and comprehensive search strategy, with a clear focus on identifying papers that describe the development of a CSPBM. The aim of this review is to identify and appraise the methods used to develop these measures.
Methods
We developed a search strategy based on four groups of terms:
1. to identify papers describing the development of instruments 2. to limit the search to studies in which HSUVs were elicited to estimate a PBM (excluding those in which health states were valued for other purposes) 3. to identify papers discussing the measurement of HRQoL 4. to identify preference-based (rather than non-preference-based) instruments.
The following databases were searched: Embase, MEDLINE, PsycINFO, Web of Science, the Cochrane Library, CINAHL, EconLit, ASSIA and the Health Management Information Consortium (HMIC) database. In addition, citation searching, a Google search and searches of the discussion papers published on the Sheffield School of Health and Related Research (ScHARR) Health Economics and Decision Science website were undertaken. An example search strategy and full details of the databases searched are presented in the Electronic Supplementary Material (ESM).
The review includes papers that relate to an instrument that is designed for a single named condition or a related group of conditions (e.g. multiple sclerosis or neurological conditions, glaucoma or visual impairment); and relate to an instrument that provides a classification system, based on HRQoL, functioning or symptoms, that is capable of categorising all patients with the condition; and relate to an instrument for which an algorithm has been developed to enable preference weights to be calculated for all health states defined by the classification system, or where the intention to develop such an algorithm has explicitly been stated; and provide an account of the development or validation of such an instrument, whether all or part of the development process, including revaluations of existing instruments using a different population; or review various CSPBMs.
The review excludes papers that use demographic or other factors, either alone or in combination with items drawn from HRQoL questionnaires, to predict utility; or are not written in English; or are commentaries, editorials, letters, conference abstracts or dissertations; or provide an account of health state valuation if this does not form part of the development of a CSPBM; or concern the development of a bolt-on dimension to an existing generic measure.
The original search was undertaken in July 2011 and was repeated in July 2013 and July 2015. In total, the searches produced 11,706 results (including some duplicates due to slight overlaps between the dates covered by the searches). Titles and abstracts were assessed independently by two reviewers to exclude any papers that were not relevant to the review. Through cross-referencing and discussion, both reviewers agreed on a shortlist of potential studies for inclusion. Conference abstracts, dissertation, abstracts and project records, for which the full text was not available, were excluded (the reviewers included fulltext manuscripts corresponding to two conference abstracts, in the form of two papers that had been accepted for publication). The full text of the remaining papers was obtained for assessment against the inclusion and exclusion criteria. In total, across the three literature searches, this resulted in the identification of 86 papers, covering the development of 51 instruments (Fig. 1) . Assessment of the papers against the inclusion and exclusion criteria was undertaken independently by both authors; no disagreements arose.
Data were extracted using a data-extraction form structured around the process for developing a PBM (please see the ESM).
Results

Overview of the Literature
The literature search yielded 86 publications that met the inclusion criteria for the review, including the four previous reviews outlined above (see Fig. 1 ). The remainder described the development of 51 different CSPBMs, including two classification systems that were yet to be valued. Some authors reported the entire process of developing a measure in a single paper, while others reported the development of the classification system and the estimation of the tariff separately. Table 1 links the papers that discuss the development of each measure, and summarises some of the key features of the CSPBMs, as discussed below.
As outlined above, PBMs can be used in cost-effectiveness analyses to inform resource allocation across the healthcare system, by generating the HSUVs required for the calculation of QALYs, and they can also be used to inform decision analysis at an individual or clinical level. Only around two-thirds of the identified studies aimed to produce an instrument capable of generating QALY weights. The remainder produced an instrument purely for individual or clinical-level decision making, and stated that their measures were not designed to generate QALYs. These studies aimed to identify the factors that influence patients' experiences of living with disease and that inform patients' and clinicians' decisions with respect to treatment alternatives, to quantify the relative importance of these factors, and to produce instruments capable of informing resource allocation within the condition of interest from a patient perspective.
Common areas for CSPBM development were cancer (eight instruments), urinary, gynaecological and sexual health issues (eight), respiratory conditions (seven), neurological conditions (seven), mental health or cognitive deficits (five), vision (three) and oral health (two). Onethird of the classification systems focused solely on specific symptoms without considering wider impacts on HRQoL. The majority (62.7 %) had between four and six dimensions, and the total number of health states ranged from nine to several million. Nearly half of the studies were UK based and around one-fifth were undertaken in the USA. Three different sets of scaling anchors were used: perfect health and being dead, the best health state described by the classification system and being dead, and the best and worst health states described by the classification system. Only two studies [11, 42] produced tariffs that included negative values.
The classification systems for 33 of the CSPBMs were derived from existing non-PBMs; 18 were developed de novo. Table 2 presents the methods employed by studies that derived a classification system from an existing measure. The main reasons provided for selecting a particular instrument as the basis for a CSPBM were wide usage in clinical and research settings, psychometric properties, suitability for a range of condition subtypes or severity levels, and coverage of dimensions considered important by patients. One study [22] based their choice on a systematic comparison of available HRQoL measures.
Methods for the Development of Classification Systems
Derivation from an Existing Instrument
Of the 33 classification systems derived from an existing instrument, 12 adopted the 'health state classification approach' developed by Brazier et al. [1] , which employs statistical techniques to determine the dimensional structure of an instrument, followed by a combination of traditional psychometric analysis with one of the 'new' psychometric techniques (Rasch analysis or item-response theory) to select one item to represent each dimension. Rasch analysis is based on the idea that there is a latent scale for the construct being measured (in this case, HRQoL), on which both respondents and item-response levels are located. The probability that a respondent will give a particular response to a particular question is calculated as a logistic function of the distance between the position of the respondent and the position of that response level on the latent (logit) scale. Rasch models can be used to analyse the psychometric properties of existing scales and develop new scales [92, 93] and offer a number of Selecting an instrument Wide usage Petrillo and Cairns [60] Selecting an instrument Wide usage Petrillo and Cairns [60] Goodness of fit to Rasch model Spread across latent space advantages compared with traditional psychometric techniques 1 [94] . In the health state classification approach, item selection takes place in two phases. In the item-elimination phase, Rasch analysis is typically employed to identify and adjust items where respondents struggle to distinguish between response levels (disordered thresholds) and items that behave differently between different subgroups of respondents (differential item functioning). Items are removed if they exhibit poor fit to the Rasch model, using item chi-squared statistics, item fit residuals and measures of model goodness of fit (the item-trait interaction chi-squared statistic, mean fit residuals and the person separation index). Only the remaining, unadjusted items are considered during the item-selection phase. Item selection typically uses both new and traditional psychometric methods to compare items. Rasch analysis is used to assess the extent to which item levels cover the full range of condition severity (i.e. their spread across the latent scale). All studies also considered how well items fitted the Rasch model. The psychometric criteria employed to compare items included acceptability (missing data), item difficulty (item-response distributions), the extent to which the item measures the intended construct (internal consistency) and sensitivity to change (responsiveness). Several (n = 5) of the studies that took this approach employed expert opinion to enhance content validity and clinical relevance and to avoid redundancy. Brazier et al. [1] also recommend exploring whether the number of item-response levels can be reduced, using Rasch analysis and response frequencies; only one of these studies [71] did not do so.
The remaining studies adopted a variety of methods, primarily psychometric criteria and expert opinion, to determine dimensions and select items. In five studies, individual items were not selected to represent each dimension; instead, item responses were summed to produce overall dimension scores or new response levels were assigned to each dimension.
Developing a Classification System De Novo
The methods used for developing a classification system de novo are summarised in Table 3 . All but four studies used qualitative work with patients at some stage of the process. Six studies took an inductive approach to determining the domains to be included in their classification systems, constructing dimensions by analysing data from interviews with patients and clinicians [10, 21, 27, [75] [76] [77] . Others used a combination of statistical, qualitative and literaturebased techniques. A wide variety of methods were employed to construct and select items to represent each dimension, although relatively few studies reported using psychometric techniques [41, 48, 63, 76, 77] . Rather than developing items, eight studies constructed intra-domain statements to describe the severity levels for each dimension from analysis of qualitative interviews with patients [10, 14, 21, 24, 27, 75] or expert opinion [16, 24, 74] .
Validation
A total of 36 of the 51 classification systems were not validated. Six of the studies that derived their CSPBM from an existing measure repeated the process on a separate dataset and compared the results, as recommended by Brazier et al. [1] . Other studies undertook a separate survey to test the psychometric properties of the classification system (including test-retest reliability; convergent validity with PBMs, HRQoL measures and clinical measures; discriminative validity; responsiveness; and unidimensionality).
Other methods involved further analysis of the dataset used to develop the classification system, using Rasch tests of unidimensionality and item redundancy [45, 57] or psychometric criteria [17] , or constructing a temporary scoring index and assessing the performance of the regression model and the psychometric properties of the values generated [41] .
One vision-specific classification system [48] was validated independently by two subsequent publications [50, 52] , which described the translation of the instrument into other languages. Table 4 summarises the methods used to select health states and to elicit preferences. A total of 32 studies elicited preferences from a sample of the general population, 21 elicited preferences from people with the condition and one surveyed clinicians. With the exception of one paper that did not explicitly mention QALYs [17] , all studies that obtained valuations from the general public aimed to produce an instrument capable of producing QALY weights. Of the 21 studies that obtained valuations from patients, 18 developed non-QALY measures.
Preference-Elicitation Techniques
Composite Approach
A composite approach was adopted to estimate the tariffs for 34 classification systems. Two additional studies estimated a new tariff for an existing classification system [31, 1 Unlike traditional psychometric approaches, Rasch models produce interval scales that are based on an estimate of the true score rather than relying on observed scores. Item parameters are estimated independently of the sample used for scale construction; similarly, person values are estimated independently of the items used. This avoids two limitations of traditional psychometric methods, in which results for scales are sample dependent and vice versa. Rasch models are more tolerant of missing data and do not require imputation of missing values [94] . Five classification systems were small enough for preferences to be elicited directly for all health states from all survey respondents. Among the others, the dominant methodology was to obtain valuations for health states prospectively sampled from the classification system. Samples of health states were selected from most classification systems using a statistically efficient design, such as an orthogonal array [95] . The number of conceptual dimensions represented by three classification systems [23, 45, 87] exceeded the number of statistically distinct dimensions, increasing the likelihood of interdependencies between items, and hence the possibility of a statistical design including implausible combinations of dimension levels. Therefore, these studies employed a 'Rasch vignette approach', which uses Rasch analysis to identify health states typically reported by people experiencing different levels of condition severity. This ensures that the sample contains health states that are likely to be experienced by people with the condition. Two studies [23, 35] involved people with the condition described by the health states to ensure that the selected states were plausible. All but four of these studies aimed to produce a QALY measure, several of which stated that they selected their valuation technique in order to enhance comparability with the EQ-5D or to comply with guidelines [96] issued by the UK National Institute for Health and Care Excellence (NICE) [23, 30, 42, 46, 47, 57, 61, 82, 84, 87, 89] . Three studies selected DCE methods to produce non-QALY instruments to inform decision analysis, stating that DCEs mirror the ways in which patients choose between treatment strategies [25, 28] or are more appropriate than SG or TTO approaches for chronic conditions where death is not a likely outcome [14] . The latter explanation also provided a rationale for using DCEs to elicit preferences for a QALY measure [24] . An alternative methodology, used in three studies that aimed to produce non-QALY instruments for decision analysis, was to ask people with the condition to complete the classification system, thereby reporting the health state they were currently experiencing, and then to complete a preference-elicitation exercise for their own current health [18, 44, 62] . The values provided for the respondents' own health states were used in regression analysis to obtain HSUVs for all health states described by the classification system.
Decomposed Approach
Tariffs for 15 classification systems were estimated using a decomposed approach. In addition, two studies [66, 69] estimated new tariffs for two existing classification systems [65, 68] in different populations. The sample of health states required to estimate a decomposed model is largely determined by multi-attribute utility theory. Values for dimension levels are obtained using 'single-attribute states': respondents are asked to consider each dimension in isolation and to scale the levels of the dimension relative to one another. The relative weighting of each dimension is assessed using its 'corner state', in which the relevant dimension is at its worst level and all others are at their best levels. Finally, respondents value a number of 'multi-attribute states' to estimate the power function required to convert VAS values into utility scores [97] . The most common technique was to value all single-attribute states, all corner states and a small number of multi-attribute states using VAS and to value the corner states and multi-attribute states using a choice-based method. Two studies omitted a corner state that was considered implausible [15, 63] . Four studies [15, 49, 54, 63] included fewer than the three multiattribute states required for the multiplicative multi-attribute utility function that they used to predict HSUVs [5] . Six studies provided a rationale for their choice of methods: minimising respondent burden [39, 49] , consistency with economic theory and theoretical suitability [38] , or replicating the methods of previous studies [17, 66, 69, 81] .
An alternative technique did not involve the valuation of health states. Instead, respondents were asked to weight dimensions relative to each other, then to score the levels of each dimension independently of the others, using resource-allocation tasks and VAS [10, 21, 27, 75] . Table 5 presents details of 32 composite models selected to produce tariffs for 28 classification systems, plus five models reported by one study that did not select a preferred specification [64] . Of the remaining classification systems that were valued using a composite approach, four did not require models because all health states were valued directly [33, 59, 76, 79] . One study that obtained direct valuations for all health states estimated models to predict values for members of the population outside the study sample [16] . One study did not provide details of their model [78] . The majority of models (n = 26) used either an ordinary least squares (OLS) or random effects (RE) specification. The five models based on the results of DCEs were estimated using RE probit or conditional logistic regression. A greater likelihood of interactions between items was anticipated by the developers of three classification systems in which the dimensions were highly correlated [35, 46, 87] . These studies used OLS regression models to examine the relationship between mean observed HSUVs and values on the Rasch logit scale corresponding to the health states that were directly valued.
Modelling Techniques
In 14 studies, some model coefficients were found to be inconsistent with the expected direction of preferences. In three of these studies, the final models included inconsistent coefficients [12, 64, 71] ; the remainder merged inconsistent coefficients to produce a consistent model. Twelve studies tested the inclusion of preference interactions. Eight studies employed dummy variables to capture the effect of any dimension being at its highest or lowest level [12, 13] , any dimension being at its most severe level [23, 55, 61, 72] , any dimension being at least level 3 or at least level 4 [72] or two or more dimensions being at level [84, 89] . Two studies fitted first-order interaction terms [44, 72] and three did not describe their interaction terms [16, 57, 71] . Only two studies included an interaction term in their preferred model [61, 72] . There are two reasons for evaluating the performance of models: to select the preferred model and to assess the quality of the preferred model. The following summary concerns preferred models only. Given that these models aim to predict values for health states, an important test is the difference between observed and predicted values for the health states that were directly valued. The majority of studies assessed this using the mean absolute error (MAE; n = 20); some also reported the number of health states with prediction errors [0.1 or [0.05 (n = 11). Most studies reported the number of inconsistent coefficients (n = 27) and the number of significant coefficients (n = 25). These tests can be calculated for any model specification, making them useful for comparisons between alternative models [5] . A number of other statistics were reported, including R-squared or R-squared-type statistics, root mean squared error, the Akaike information criterion, the Bayesian information criterion, the Ljung-Box statistic and the Jarque-Bera test of normality of prediction errors. Two papers reported no model performance statistics [25, 28] . Only two models that were selected to produce a tariff included inconsistent coefficients, although 11 of the preferred models included levels that had been merged to remove inconsistencies. In 19 of the 25 models for which this was reported, at least 80 % of coefficients were significant (p \ 0.05). MAEs ranged from 0.008 to 0.065. With the exception of two models [13, 60] , the percentage of health states with prediction errors [0.05 ranged from 31 to 44 %, while the percentage of errors [0.1 varied from 2 to 16 %.
In addition to the models listed in Table 5 , two studies produced alternative tariffs for existing instruments. Kharroubi et al. [86] estimated new models for two existing measures [84, 89] using non-parametric Bayesian methods in order to address certain limitations of the standard approach, in terms of the size and pattern of prediction errors and the extent to which the effects of covariates are captured. Alava et al. [90] rescaled six PBMs, including the Asthma Quality of Life-5 Dimensions (AQL-5D) [89] , onto a common scale using ranking data.
The 13 studies that directly valued individual health states to inform a decomposed model transformed the values obtained from the VAS into SG or TTO utilities prior to fitting the multi-attribute utility function, using a power curve or function. The multiplicative functional form proved the dominant model due to its ability to allow for some preference interactions between dimensions; one study found that additive models were adequate to estimate tariffs for two of their three population subsamples, but required a multiplicative model for their third subsample and their combined tariff [66] . Only five of these studies reported performance statistics to illustrate the predictive ability of their models [11, 17, 39, 69, 81] .
All four studies in which dimensions and dimension levels were valued separately used an additive multi-attribute utility functional form, which allows for no preference interactions between dimensions. None of these studies assessed the predictive ability of their models.
Validation Methods
Methods for the validation of CSPBMs are illustrated in Table 6 and discussed here in relation to recommendations made by Brazier et al. [1] . A total of 21 studies assessed the convergent validity of their measures: four compared the CSPBM with the measure from which it had been derived; eight compared it with other PBMs. Eighteen studies undertook an evaluation of discriminative validity, although only three compared this with another measure: two with the EQ-5D and one with the EQ-5D, SF-6D and the parent measure. Responsiveness was considered by eight studies, of which only two compared the responsiveness of the CSPBM with another measure. Around half of the papers that described the estimation of a tariff for one or more CSPBMs did not report any validation of their measure(s).
Ten CSPBMs were validated retrospectively in subsequent publications [19, 20, 36, 40, 50-53, 67, 73, 85, 91] . These adopted a range of methods, including comparisons with algorithms that map from the parent measure of the CSPBM to EQ-5D values. Brazier et al. [1] conducted retrospective validations of four instruments [46, 71, 84, 89] following their own recommended procedure.
Discussion
Methods for Developing a Classification System
Two methodological frameworks for the development of classification systems have been proposed: one for the derivation of classification systems from existing measures [1] and one for the development of classification systems de novo [77] .
Derivation from Existing Instruments
Brazier et al. [1] have developed the 'health-state classification approach', which provides a guide to the methods for deriving a classification system from an existing HRQoL measure, while minimising the loss of descriptive information and enabling HSUVs to be estimated from responses to the original measure. The majority of papers describing the derivation of a CSPBM from an existing measure that had been published since 2009 used this approach, although relatively few followed its recommendations for validation. This suggests that the health state classification approach is emerging as the dominant method for deriving a classification system from an existing measure. Differences were apparent between these studies; however, this approach is intended as a guide that should be adapted to each particular application, rather than a rigid methodological process. Across all studies in which individual items were selected from the original measure, all but one [79] used traditional psychometric criteria, Rasch analysis or factor analysis to do so. Given the strong emphasis that the health state classification approach places on new psychometric techniques, it is unsurprising that the use of Rasch analysis has increased substantially in recent years. Expert opinion retains a significant role at various points in the process, illustrating that however robust the statistical methods may be, it remains important to check that their results make clinical sense.
Among those studies that used an existing instrument as the basis for a CSPBM, only one [22] reported undertaking a systematic comparison between candidate measures to provide a robust justification for selection of a particular instrument, suggesting that this could be a fruitful area for future research.
Deriving a classification system from an existing measure may increase the scope for the PBM to be adopted in cost-effectiveness studies. The PBM can be applied to existing datasets that contain the original measure, enabling retrospective economic evaluations to be undertaken. Furthermore, selecting an instrument that is well accepted by relevant clinical and research communities may enhance the acceptability of the PBM. However, HRQoL measures were not intended for this purpose and not all will provide a suitable basis for a PBM [5] . Where no suitable measure is available, the classification system will have to be developed de novo [1] .
Development De Novo
Stevens and Palfreyman [77] have recommended a best practice method for developing a classification system de novo, in which dimensions and items are derived inductively from analysis of qualitative interviews with patients or the public. One-third of the de novo studies employed this approach [10, 21, 27, [75] [76] [77] , although the majority of studies involved people with the relevant health condition at some stage.
Notwithstanding their recommendations for a 'bottomup', qualitative approach, it is notable that Stevens and Palfreyman made extensive use of new and traditional psychometric methods when selecting items for their classification system [77, 78] . Given that classification systems are intended for use as questionnaires to be completed by people with the relevant condition, one may expect developers to use similar methods to those used in the construction of non-preference-based HRQoL measures. This typically involves analysis of a dataset containing a draft version of the classification system, using either new or traditional psychometric techniques, in combination with insights derived from patients, clinical experts or the relevant literature [1] . However, only six of the 18 de novo studies reported that they had evaluated the psychometric properties of items in the development [41, 48, 63, 76, 77] or validation [41, 63, 74] of their classification systems. This limits the range of evidence available to support the validity of many classification systems that were developed de novo, particularly compared with those derived from existing instruments, the majority of which employed psychometric techniques to select items.
Methods for Generating a Tariff
Context appears to be an important factor in the selection of methods for estimating HSUVs for a CSPBM. As we have seen, most studies that designed non-QALY instruments for decision analysis in condition-specific settings elicited preferences from patients and used a decomposed approach, which explicitly weights dimensions relative to one another, arguably providing a more appropriate method for identifying the factors of greatest importance to patients. Conversely, the requirements of national decisionmaking bodies were a key determinant of the methods adopted by studies that aimed to produce a QALY measure; for example, the UK studies tended to follow NICE guidance, which stipulates that tariffs should be statistically modelled from societal preferences, elicited using the Measurement and Valuation of Health variant of the TTO technique [96] . The importance of context is supported by the predominance of QALY measures developed in settings that rely on QALY-based frameworks to inform resource allocation for the healthcare system overall, in contrast to the predominance of non-QALY-based decision-analysis tools in the US setting, where patients pay for medical treatment either directly or via insurance, leading to a greater focus on patients' perceptions of health status and treatment outcomes.
Dolan [98] has argued that methodological considerations may determine the choice between decomposed and composite approaches. The extent to which this is reflected in the approaches adopted by the included studies is mixed. First, as the size of the classification system increases, so does the size of the sample of health states required to estimate a composite model, whereas the number of states required for a decomposed model remains constant. Dolan suggests, therefore, that the decomposed approach may be better suited to larger classification systems. This appears to be reflected in the included studies: six of the 34 classification systems that were valued using a composite approach described more than 10,000 health states, compared with nine of the 15 that were valued using the decomposed approach (Tables 1, 4) . Second, he asserts that the decomposed approach may be less appropriate for classification systems that include correlated dimensions, due to the restrictions it places on preference interactions between dimensions and its requirement to obtain valuations for potentially implausible corner states [97] . The findings of this review do not indicate that the potential for interactions between dimensions influenced the choice of approach. Most of those that followed a decomposed strategy allowed for limited preference interactions by fitting multiplicative models to their data, whereas only four that followed a composite strategy specifically avoided selecting implausible states and only two found that an interaction term improved the predictive ability of their model (indeed, most did not report testing for preference interactions). A further implication of dimension orthogonality is that dimensions defined according to specific symptoms are more likely to be structurally independent than dimensions that reflect broader impacts on HRQoL. This indicates that a composite strategy may be better suited to classification systems that describe the impact of the condition on HRQoL. There is some evidence that the included studies followed this pattern. As Table 1 shows, 17 classification systems did not include dimensions that describe the impact of the condition on aspects of people's HRQoL, focusing instead on describing symptoms of the condition. Of the 34 classification systems that were valued using a composite approach, 23 included HRQoL attributes, compared with six of the 15 that were valued using the decomposed approach.
It has been suggested that the decomposed approach provides a stronger theoretical foundation due to its basis in multi-attribute utility theory. Dolan [98] asserts that this theoretical advantage is largely irrelevant if it does not enhance the ability to predict HSUVs. One [61] of the included studies estimated both a composite and a decomposed algorithm for the same classification system, concluding that the algorithms performed similarly well in terms of responsiveness and discriminative validity. Following their review of the methods for converting condition-specific measures into PBMs, Petrillo and Cairns [8] found no evidence to prefer either a composite or a decomposed approach.
Among the studies that took a composite approach, model selection was generally based on the difference between observed and predicted values, the proportion of coefficients that were consistent and the proportion of coefficients that were significant. The performance of the preferred models varied considerably. Few of the studies that took a decomposed approach reported performance statistics to illustrate the predictive ability of their models (n = 5).
Young et al. [87] and Mavranezouli and colleagues [45, 46] developed novel approaches to valuation and modelling based on Rasch analysis. While most studies adopted statistically efficient designs to select health states for inclusion in the valuation survey, these authors noted that such designs may generate implausible health states when applied to classification systems with interdependent dimensions. This led to the development of the Rasch vignette approach, which provides a method for selecting health states based on the combinations of item levels that are most likely to be experienced by people with the condition. Rather than using individual dimension levels as the independent variables in the regression analysis, these studies used corresponding Rasch logit values for health states to predict HSUVs. Two subsequent studies have used similar techniques to select a sample of health states [23] or predict HSUVs [35] . Although some issues remain to be resolved, particularly the ability of the technique to predict values for individual health states rather than groups of states based on total dimension-level scores [23] , this is a promising new approach that is an important area for further research.
Validation Methods
Brazier et al. [1] recommend that the validity and responsiveness of the CSPBM should be assessed in comparison with generic PBMs and (where appropriate) the parent measure. However, relatively few papers reported a thorough validation of their measure. It is worth noting that a number of validations were reported in subsequent papers, therefore validations of some instruments may be reported in future publications. Where validation was undertaken, this seldom adhered to these best practice methods. Convergent and discriminative validity were reasonably well covered, responsiveness less so, possibly due to a lack of access to longitudinal data.
Tariffs and Values
For the results of CSPBMs to be used to calculate QALYs, the valuations for health states described by the CSPBM should lie on a scale from full health (one) to being dead (zero) [1] . All instruments with values anchored against the worst and best possible health states were designed for decision analysis only, not for estimating QALYs. Among those studies that sought to develop a QALY measure, all anchored the state of being dead at zero. A total of 18 selected an upper anchor of generic full health, while 12 used an upper anchor of condition-specific full health (the best health state described by the classification system). The definition of 'full health' is a subject of debate in the literature.
Condition-specific full health is not necessarily equivalent to perfect health. Respondents to a valuation survey may assume that patients in the best possible health state may have decrements on dimensions that are not included in the classification system, due to the condition itself or due to co-morbidities [99] . Brazier et al. [1] assert that comparability is problematic between instruments that do not share a common upper anchor; therefore, PBMs should be anchored against death and generic full health rather than the best possible health state.
Only two of the condition-specific tariffs included negative HSUVs [11, 42] , despite that several instruments were developed for conditions that cause severe decrements in HRQoL. One hypothesis is that the relatively narrow coverage of HRQoL attributes by condition-specific classification systems compared with the EQ-5D allows valuation survey respondents to assume high levels of function on other HRQoL attributes [1] . However, it is notable that another popular generic PBM, the SF-6D, also has no negative values [3] . Further research is required to understand this phenomenon.
Conclusion
This paper presents a detailed systematic review of the literature describing the development of CSPBMs. The most relevant previous review included 26 papers [1] . The literature search reported here identified 43 papers published since this earlier review and included 17 additional papers, providing an up-to-date and comprehensive review of the literature in this area.
A wide range of methods have been used at all stages of CSPBM development, within two overarching groups of approaches for construction of the classification system (derivation from an existing instrument and de novo) and two for the estimation of the tariff (composite and decomposed methods). The choice between developing a classification system de novo or from an existing instrument may depend largely on the availability of a suitable existing measure. The choice between a decomposed or composite approach appears to be determined primarily by the purpose for which the instrument is designed (QALY generation or individual/clinical-level decision analysis), although considerations regarding the size of the classification system and practical constraints on the proportion of health states that can be valued directly may play a part. More comparative studies are required to provide empirical evidence on the relative merits of these competing approaches. Despite the recent publication of recommended methods for validation [1] , uptake of these appears to have been relatively low, and this remains an area for further development.
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